News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
311,158 Results
Type
Article (14327)
Company Profile (109)
Press Release (296722)
Multimedia
Podcasts (47)
Webinars (10)
Section
Business (99371)
Career Advice (570)
Deals (20508)
Drug Delivery (67)
Drug Development (39976)
Employer Resources (49)
FDA (7003)
Job Trends (7176)
News (171172)
Policy (15546)
Tag
Academia (506)
Accelerated approval (2)
Adcomms (6)
Allergies (37)
Alliances (26474)
ALS (44)
Alzheimer's disease (488)
Antibody-drug conjugate (ADC) (45)
Approvals (7051)
Artificial intelligence (116)
Autoimmune disease (9)
Automation (4)
Bankruptcy (189)
Best Places to Work (5269)
BIOSECURE Act (9)
Biosimilars (59)
Biotechnology (46)
Bladder cancer (26)
Brain cancer (16)
Breast cancer (98)
Cancer (792)
Cardiovascular disease (76)
Career advice (501)
Career pathing (12)
CAR-T (26)
Cell therapy (108)
Cervical cancer (4)
Clinical research (33742)
Collaboration (385)
Compensation (180)
Complete response letters (17)
COVID-19 (813)
CRISPR (22)
C-suite (131)
Cystic fibrosis (43)
Data (825)
Denatured (15)
Depression (13)
Diabetes (100)
Diagnostics (1906)
Digital health (3)
Diversity (2)
Diversity, equity & inclusion (13)
Drug discovery (64)
Drug pricing (68)
Drug shortages (12)
Duchenne muscular dystrophy (37)
Earnings (36488)
Editorial (12)
Employer branding (4)
Employer resources (43)
Events (44319)
Executive appointments (436)
FDA (7524)
Friedreich's ataxia (2)
Frontotemporal dementia (2)
Funding (273)
Gene editing (42)
Generative AI (9)
Gene therapy (106)
GLP-1 (363)
Government (1421)
Grass and pollen (3)
Guidances (27)
Healthcare (5076)
Huntington's disease (4)
IgA nephropathy (12)
Immunology and inflammation (37)
Indications (15)
Infectious disease (857)
Inflammatory bowel disease (66)
Inflation Reduction Act (6)
Influenza (19)
Intellectual property (55)
Interviews (77)
IPO (9203)
IRA (29)
Job creations (2150)
Job search strategy (448)
Kidney cancer (6)
Labor market (12)
Layoffs (182)
Leadership (4)
Legal (3953)
Liver cancer (19)
Lung cancer (113)
Lymphoma (63)
Machine learning (2)
Management (16)
Manufacturing (174)
MASH (37)
Medical device (2942)
Medtech (2944)
Mergers & acquisitions (11700)
Metabolic disorders (290)
Multiple sclerosis (24)
NASH (14)
Neurodegenerative disease (24)
Neuropsychiatric disorders (8)
Neuroscience (704)
NextGen: Class of 2025 (2220)
Non-profit (725)
Now hiring (8)
Obesity (157)
Opinion (121)
Ovarian cancer (28)
Pain (62)
Pancreatic cancer (30)
Parkinson's disease (58)
Partnered (10)
Patents (140)
Patient recruitment (37)
Peanut (11)
People (31916)
Pharmaceutical (64)
Pharmacy benefit managers (12)
Phase I (9082)
Phase II (14506)
Phase III (12455)
Pipeline (550)
Policy (73)
Postmarket research (1427)
Preclinical (3659)
Press Release (26)
Prostate cancer (52)
Psychedelics (8)
Radiopharmaceuticals (138)
Rare diseases (181)
Real estate (2947)
Recruiting (17)
Regulatory (11108)
Reports (16)
Research institute (653)
Resumes & cover letters (67)
Rett syndrome (1)
RNA editing (2)
RSV (11)
Schizophrenia (41)
Series A (44)
Series B (19)
Service/supplier (3)
Sickle cell disease (37)
Special edition (6)
Spinal muscular atrophy (78)
Sponsored (6)
Startups (1887)
State (2)
Stomach cancer (4)
Supply chain (34)
Tariffs (32)
The Weekly (30)
Vaccines (174)
Venture capitalists (14)
Weight loss (100)
Women's health (8)
Worklife (4)
Date
Today (56)
Last 7 days (336)
Last 30 days (1055)
Last 365 days (14208)
2025 (4650)
2024 (15349)
2023 (17676)
2022 (23558)
2021 (24856)
2020 (23766)
2019 (18185)
2018 (14264)
2017 (16086)
2016 (14953)
2015 (18006)
2014 (14142)
2013 (11993)
2012 (12940)
2011 (13195)
2010 (12114)
Location
Africa (317)
Alabama (15)
Alaska (1)
Arizona (78)
Arkansas (3)
Asia (22142)
Australia (2894)
California (2286)
Canada (1018)
China (274)
Colorado (84)
Connecticut (103)
Delaware (70)
Europe (42143)
Florida (432)
Georgia (55)
Idaho (14)
Illinois (232)
India (16)
Indiana (156)
Iowa (1)
Japan (102)
Kansas (63)
Kentucky (14)
Louisiana (1)
Maine (37)
Maryland (324)
Massachusetts (1841)
Michigan (91)
Minnesota (118)
Mississippi (2)
Missouri (26)
Montana (10)
Nebraska (8)
Nevada (33)
New Hampshire (12)
New Jersey (927)
New Mexico (8)
New York (738)
North Carolina (545)
North Dakota (2)
Northern California (909)
Ohio (67)
Oklahoma (4)
Oregon (18)
Pennsylvania (581)
Puerto Rico (8)
Rhode Island (13)
South America (534)
South Carolina (7)
Southern California (963)
Tennessee (43)
Texas (345)
United States (9504)
Utah (69)
Virginia (83)
Washington D.C. (31)
Washington State (166)
West Virginia (1)
Wisconsin (24)
311,158 Results for "ascendia pharmaceuticals llc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Ascendia Pharmaceutical Solutions Launched to Meet Drug Development and Manufacturing Needs
December 10, 2024
·
2 min read
Ampio Selects Ascendia Pharmaceuticals, Inc. to Provide CDMO Services to Support Clinical Development of OA-201
Ampio Pharmaceuticals, Inc. (NYSE American: AMPE) (the “Company) today announced that it has selected Ascendia Pharmaceuticals, Inc. (“Ascendia”) to provide services to support the clinical development of OA-201, a novel therapeutic for the treatment of symptomatic osteoarthritis pain.
October 5, 2023
·
5 min read
Pharm Country
Ascendia Pharmaceuticals Develops Novel Nanoemulsion IV Formulation for Clopidogrel that Received IND Approval
Ascendia Pharmaceuticals CEO Jim Huang, Ph.D. announces Ascendia’s patented EmulSol® nanotechnology has been used to develop a novel nanoemulsion IV formulation for clopidogrel that has received Investigational New Drug (IND) approval from the Food & Drug Administration (FDA).
June 27, 2023
·
2 min read
Pharm Country
Ascendia® Named to 2023 Inc. 5000 List of America’s Fastest-Growing Private Companies for the Fourth Consecutive Year
Ascendia Pharmaceuticals® proudly announces it has been named to the prestigious 2023 Inc. 5000 list for the fourth consecutive year.
August 24, 2023
·
3 min read
Press Releases
Innovative Lab Services LLC Acquires Compco Analytical, Inc.
May 1, 2025
·
1 min read
Press Releases
Acella Pharmaceuticals, LLC, an Alora Pharmaceuticals, LLC Subsidiary, Partners with Paloma Health for Hypothyroidism Patients
October 23, 2024
·
2 min read
Press Releases
AEON Biopharma Reports Inducement Grants Under NYSE American LLC Company Guide Section 711
April 22, 2025
·
2 min read
Press Releases
Marius Pharmaceuticals Partners with US Specialists Management, LLC (“USSM”) Through Affiliated Urologic In-office Dispensaries
January 14, 2025
·
7 min read
Press Releases
Pharma Logistics, LLC and Rx Reverse Distributors, Inc. Unite, Setting a New Standard in Pharmaceutical Reverse Distribution
January 6, 2025
·
3 min read
Press Releases
Calidi Biotherapeutics Reports Inducement Grant Under NYSE American LLC Company Guide Section 711 - April 25, 2025
April 28, 2025
·
3 min read
1 of 31,116
Next
